Do Alzheimer’s Patients Forget How to Walk?

Alzheimer’s disease does eventually rob many patients of the ability to walk, but it rarely happens the way people imagine. The loss is not a sudden moment where someone “forgets” the mechanics of putting one foot in front of the other. Instead, walking deteriorates gradually over years through a combination of brain changes, muscle decline, and eroding coordination. One large prospective study found that walking ability declined at a mean rate of about 13% per year among community-dwelling Alzheimer’s patients.¹ Understanding what drives that decline, and what can slow it down, matters for patients and the people caring for them.

How Walking Changes as the Disease Progresses

Even in the early stages of Alzheimer’s, walking looks subtly different from normal aging. People with early-stage disease walk slower, take shorter strides, and spend more time with both feet on the ground compared to healthy older adults.² These differences might not be obvious to a casual observer at first, but they show up clearly on instrumented walkways and motion sensors.

Over time, those changes accelerate. A longitudinal study tracking Alzheimer’s patients over one year found that walking speed dropped from about 104 cm/s to 95 cm/s, stride length shortened, and the variability of each stride increased substantially, meaning steps became less rhythmic and predictable.³ These changes occurred in people with mild disease, not just those in advanced stages. By the time someone has progressed to late-stage Alzheimer’s, their gait speed is considerably slower and step-to-step variability is markedly higher than in people who remain at the mild cognitive impairment stage.⁴

In advanced disease, the decline can become total. Many patients eventually become wheelchair-bound or bedbound. When walking is lost entirely, the body often develops contractures, where joints stiffen into fixed positions. Research has found that more than three-quarters of Alzheimer’s patients who had lost the ability to walk showed contractures, typically in multiple limbs, while fewer than one in ten patients who could still walk had them.⁵ Contractures tend to happen because immobility leads joints and soft tissue to tighten, creating a vicious cycle where the loss of walking makes recovery even harder.

Why the Brain Struggles to Control Walking

Walking feels automatic, but it actually requires a surprising amount of brain power. The spinal cord and brainstem handle the basic rhythmic pattern of leg movement, but the cerebral cortex is deeply involved in balance, route planning, obstacle avoidance, and adapting your gait to different surfaces. Alzheimer’s disease attacks many of the cortical regions that support these higher-level walking functions.

Recent imaging research has clarified how the hallmark proteins of Alzheimer’s interfere with motor control. Tau protein accumulating in the prefrontal, sensorimotor, and parietal areas of the brain is directly linked to motor problems, even after accounting for other forms of brain damage.⁶ The effect varies by brain region: tau in the parietal lobe disrupts motor function through its impact on visuospatial processing (the brain’s ability to judge space and distance), while tau in the prefrontal and sensorimotor cortex seems to interfere with movement more directly, without going through a cognitive middleman. Separately, increased neurodegeneration in the primary motor cortex has been associated with lower walking speed.⁷

Brain imaging has also connected slower gait pace and greater gait variability to widespread amyloid deposits and cortical atrophy in regions like the inferior parietal lobule, precuneus, and insula.⁸ Notably, white matter damage in the brain, visible as white matter hyperintensities on MRI, is independently associated with slower gait speed across clinical stages of the disease.⁹ These white matter tracts are the wiring that connects brain regions, so when they degrade, the coordination between the parts of the brain that plan and execute movement suffers.

The Dual-Task Problem

One of the most revealing findings in this area is what happens when Alzheimer’s patients try to walk and do something else at the same time. Healthy older adults can usually walk and carry on a conversation without much trouble. For someone with Alzheimer’s, adding a second task while walking, even something as simple as carrying a tray or counting backward, causes their gait to deteriorate far more dramatically than it does in healthy peers.¹⁰

This happens because walking in Alzheimer’s patients draws more heavily on executive brain resources, the mental processes responsible for planning, attention, and multitasking. When those resources are already compromised by the disease and then divided between walking and a second task, gait variability shoots up. Research has shown that executive function is significantly linked to the increased gait variability that occurs during divided attention, though not necessarily to gait speed during simple, undistracted walking.¹¹ Motor dual-tasks, like carrying an object, also cause meaningful drops in speed and stride length and increases in gait variability.¹²

This matters practically, not just scientifically. Real life is full of dual-task situations: walking to the kitchen while thinking about what to eat, navigating a hallway while talking to a caregiver, stepping off a curb while scanning for traffic. Each of those everyday moments is a fall risk for someone whose brain can no longer run walking on autopilot.

Gait Apraxia and “Forgetting” How to Walk

The closest phenomenon to literally forgetting how to walk is something called gait apraxia. Apraxia means the loss of the ability to carry out skilled movements despite having the physical capacity to do so. In gait apraxia, a person’s legs work fine in a strength and sensation sense, but the brain has lost the higher-level motor programming needed to coordinate them into purposeful walking. Research has found that about 40% of Alzheimer’s patients in one study fell below the threshold score on a walking skills test designed to detect gait apraxia, and their performance correlated strongly with both limb apraxia and dementia severity.¹³

So for a meaningful subgroup of patients, “forgetting how to walk” is not just a metaphor. The neural blueprints for organizing a walking sequence genuinely break down. But gait apraxia is distinct from muscle weakness, joint problems, or medication side effects, and recognizing it as a separate cause of walking difficulty is clinically important because the management approaches differ.

Balance, Falls, and Spatial Disorientation

Walking difficulty in Alzheimer’s is not just about the legs. Postural stability, the ability to stay upright and recover from small perturbations, is significantly impaired even in mild to moderate disease. A systematic review found strong evidence that older adults with mild to moderate Alzheimer’s have worse static and functional balance than healthy peers, with loss of visual input and attentional demands during dual-task activity being key factors in that instability.¹⁴ In unilateral stance tests (standing on one leg), Alzheimer’s patients fell more frequently and the time before falling was shorter even after adjusting for age and other factors.¹⁵

On top of balance problems, spatial disorientation adds another layer of difficulty. Alzheimer’s disease is well known for impairing the ability to navigate environments, and studies using virtual reality navigation tests have found that poor wayfinding performance predicts real-world spatial disorientation scores.¹⁶ A person might be physically capable of walking to the bathroom but unable to figure out the route. This is a different kind of mobility loss than a gait disorder, but for the person living with it, the result is the same: they cannot get where they need to go independently.

Muscle Loss Makes Everything Worse

The brain changes of Alzheimer’s do not operate in isolation. A phenomenon that compounds the walking problem is sarcopenia, the progressive loss of muscle mass and strength. People with Alzheimer’s have high rates of sarcopenia, and it appears strikingly early: decreased muscle strength in the lower extremities has been documented in patients with early-stage disease, before muscle mass itself has measurably dropped.¹⁷ By moderate-stage disease, both strength and mass decline together.

Several factors drive this. Alzheimer’s patients tend to become less physically active as the disease progresses, which leads to deconditioning. They may eat less or eat poorly, contributing to nutritional deficits. And the brain changes themselves may play a direct role: the same white matter damage that slows gait is also linked to measures of muscle function, suggesting that brain and muscle deterioration share overlapping pathways in this disease.⁹ The result is a compounding spiral: brain damage makes walking harder, reduced walking leads to muscle loss, and muscle loss makes walking harder still.

Gait Speed as an Early Warning Sign

One of the more striking research findings is that walking speed starts declining years before a dementia diagnosis. In a long-running study, people who eventually developed mild cognitive impairment showed an acceleration in the rate of gait speed decline roughly 12 years before their diagnosis.¹⁸ Another study found that baseline walking speed predicted cognitive decline over periods of up to 15 years.¹⁹ Across a review of 39 studies involving over 57,000 participants, the vast majority found a significant association between slow gait speed and later cognitive decline or dementia.²⁰

This does not mean that every person who starts walking slowly is developing Alzheimer’s. Plenty of conditions slow gait speed, from arthritis to depression to heart disease. But the consistency of the link has researchers interested in gait speed as a simple, low-cost screening tool that could flag people for further cognitive testing. A stopwatch and a hallway can capture information that expensive brain scans also detect.

Medications That Can Help or Hurt

The medications used to treat Alzheimer’s have a complicated relationship with mobility. Cholinesterase inhibitors, the most commonly prescribed class of Alzheimer’s drugs, were associated with a reduced risk of walking decline in one large prospective study.¹ However, a separate study found that treatment with these same medications was associated with a roughly 60% increase in fall hazard, after adjusting for age and other medications.²¹ The contradiction may partly reflect how these drugs work: they can improve attention and cognition (which supports walking), but their side effects, including dizziness and gastrointestinal symptoms, may increase fall risk through different pathways.

The picture is further complicated by other medications Alzheimer’s patients commonly take. Psychotropic drugs, including antipsychotics, benzodiazepines, and antidepressants, are frequently prescribed to manage the behavioral symptoms of dementia. Their use has been associated with slower gait, poorer balance, and an increased rate of falls.²² Antidepressant use in particular was linked to a higher fall rate, though when depressive symptoms themselves were accounted for, the medication’s independent contribution faded, suggesting that the depression itself, not just the drug, plays a role. This is an area where caregivers and clinicians need to carefully weigh the benefits of behavioral symptom control against the mobility costs.

What Exercise and Physical Therapy Can Do

The evidence is encouraging that physical activity can meaningfully slow the deterioration of walking in people with dementia. A systematic review and meta-analysis found that exercise improved both cognitive ability and walking ability, with aerobic training and multicomponent programs showing the best results.²³ Interestingly, that same review found that a moderate number of training sessions (fewer than 30 total) produced the best outcomes, suggesting that intensity and consistency matter more than sheer volume.

A training program specifically designed for elderly people with dementia found that participants in the exercise group improved their walking speed and stride length and reduced double limb support time, while those in the control group actually got worse on the same measures.²⁴ Physical therapy targeting balance and gait has shown similar improvements across multiple levels of cognitive impairment.²⁵

Exercise also seems to reduce the fall risk from medications. Among Alzheimer’s patients taking psychotropic drugs, those in a tailored exercise program had a dramatically lower fall rate than those receiving usual care.²⁶ The effect was large enough to suggest that structured exercise might partly counteract the mobility penalties of necessary medications.

Making the Home Safer

While exercise addresses the person’s capacity to walk, modifying the physical environment addresses the hazards they encounter. This is often overlooked in discussions about Alzheimer’s and mobility, but the evidence for home modifications is solid. A randomized trial found that changes to the home environment reduced fall risk in older adults with dementia.²⁷ Nurse-led home modification programs, where a professional assesses the home and recommends specific changes, have shown significant reductions in falls during follow-up periods.²⁸

Technology can add another layer of protection. A pilot study of a home-based system combining an automated nighttime light path with a teleassistance service found that its use was associated with a significant reduction in indoor falls among people with mild to moderate Alzheimer’s disease.²⁹ The rationale is straightforward: many falls happen at night when a person with impaired spatial awareness gets up in the dark. A well-lit path to the bathroom reduces the demand on a brain that is already struggling with navigation.

Practical home modifications include removing loose rugs, installing grab bars in bathrooms, improving lighting along common routes, reducing clutter, and using contrasting colors to help someone visually distinguish doorways and furniture edges. These changes cost relatively little and address the reality that a person with Alzheimer’s cannot compensate for environmental hazards the way a cognitively healthy person can.

The Retrogenesis Framework

There is an influential concept in Alzheimer’s research called retrogenesis, which observes that the functional abilities lost in Alzheimer’s disease tend to disappear in roughly the reverse order of how they were acquired in childhood development.³⁰ A child learns to sit before standing, stand before walking, and walk before managing complex tasks like dressing or cooking. In Alzheimer’s, the complex tasks go first, then walking deteriorates, and eventually even the ability to sit upright and hold up the head may be lost.

This framework helps set realistic expectations for caregivers. It suggests that if a person is still managing dressing and basic hygiene, their walking is unlikely to fail catastrophically in the near term. Conversely, when those intermediate skills start to go, it is a signal that walking will come under increasing pressure and that proactive steps, like starting an exercise program, reducing fall hazards, and reviewing medications, become more urgent.

When Walking Problems Are Not Just Alzheimer’s

Not every walking difficulty in a person with Alzheimer’s is caused by Alzheimer’s. Older adults commonly have arthritis, peripheral neuropathy, spinal stenosis, and other musculoskeletal or neurological conditions that affect gait independently. The REAL.FR study found that painful osteoarthritis nearly doubled the risk of walking decline, and hospitalization for a lower-limb fracture increased the risk more than sixfold.¹ These are treatable or at least manageable conditions, and assuming that all mobility loss is “just the Alzheimer’s” can mean missing opportunities to help.

One condition worth special mention is normal pressure hydrocephalus, a buildup of fluid in the brain that causes a distinctive triad of walking difficulty, urinary incontinence, and cognitive impairment. Because it can mimic Alzheimer’s symptoms, it sometimes goes undiagnosed. Imaging techniques can help differentiate it from Alzheimer’s and other dementias.³¹ This matters because normal pressure hydrocephalus is one of the few causes of dementia-like symptoms that can be surgically treated. If a person with apparent cognitive decline is also shuffling and having bladder issues, it is worth pushing for a thorough workup rather than accepting the first diagnosis.

The re-emergence of primitive reflexes, involuntary responses like the grasp reflex that are normal in infants but typically disappear in early childhood, has been observed alongside gait abnormalities in Alzheimer’s patients, particularly as the disease becomes more severe. The presence of these reflexes has been linked to higher rates of rigidity and apraxia, suggesting deeper neurological regression. Recognizing these signs in a clinical setting can help clinicians gauge how far the disease has progressed and adjust their mobility management strategy accordingly.